Skip to main content
Retour
Watch Compare

Fuse Medical, Inc.

Qualité des données : 100%
FZMD
OTC Wholesale Trade Durable Goods Wholesale
0,02 €
0,00 € (0,00%)
Cap. Boursière: 1,48 M
Prix
0,02 €
Cap. Boursière
1,48 M
Fourchette du Jour
0,02 € — 0,02 €
Fourchette 52 Semaines
0,02 € — 0,10 €
Volume
142 040
Ouverture 0,02 €
Moyenne 50J / 200J
0,04 €
46,81% below
Moyenne 50J / 200J
0,06 €
67,53% below

Quick Summary

Points Clés

Revenue declined -8,28% annually over 5 years
Net margin of 19,72% shows strong profitability
Generating 18 641,0 in free cash flow
P/E of 0,41 — trading at a low valuation

Croissance

Revenue Growth (5Y)
-8,28%
En dessous de la moyenne du secteur (257,90%)
Revenue (1Y)-8,67%
Earnings (1Y)N/A
FCF Growth (3Y)-59,85%

Qualité

Return on Equity
N/A
ROIC-3,30%
Net Margin19,72%
Op. Margin-1,30%

Sécurité

Debt / Equity
N/A
Current Ratio1,06
Interest Coverage-1,13

Valorisation

PE (TTM)
0,41
Au-dessus de la moyenne du secteur (-27,54)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Wholesale Trade (3 pairs)
Métrique Action Médiane du Secteur
P/E 0,4 -27,5
P/B — 1,6
ROE % — -2,8
Net Margin % 19,7 -199494,9
Rev Growth 5Y % -8,3 257,9
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -8,67% Revenue Growth (3Y) -6,66%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -8,28% Earnings Growth (5Y) -5,94%
Profitability
Revenue (TTM) 18,40 M Net Income (TTM) 3,63 M
ROE N/A ROA 19,23%
Gross Margin 64,95% Operating Margin -1,30%
Net Margin 19,72% Free Cash Flow (TTM) 18 641,0
ROIC -3,30% FCF Growth (3Y) -59,85%
Safety
Debt / Equity N/A Current Ratio 1,06
Interest Coverage -1,13 Asset Turnover 0,98
Working Capital 754 339 Tangible Book Value -3,33 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 0,41 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,08
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 1,26%
Market Cap 1,48 M Enterprise Value 1,22 M
Per Share
EPS (Diluted TTM) 0,04 Revenue / Share 0,25
FCF / Share 0,00 OCF / Share -0,01
EPS CAGR (1Y) N/A EPS CAGR (5Y) -9,64%
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 0,51%
SBC-Adj. FCF 1 649 Growth Momentum -0,39

Income Statement

Annual, most recent first
Metric FY2022 FY2021 FY2020 FY2019 FY2018
Revenue 18,64 M 20,41 M 21,40 M 22,90 M 26,34 M
Net Income 3,10 M -1,59 M -1,43 M -3,32 M 3,96 M
EPS (Diluted) 0,04 -0,02 -0,02 -0,05 0,06
Gross Profit 11,54 M 11,94 M 12,70 M 11,14 M 12,99 M
Operating Income -815 072,0 -2,20 M -1,03 M -4,35 M -1,96 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses 6,54 M 7,01 M 6,54 M 8,47 M 8,47 M
D&A 137 403,0 67 638,0 104 143,0 107 073,0 49 685,0
Interest Expense 171 294,0 78 230,0 94 953,0 121 633,0 133 944,0
Income Tax 23 655,0 17 723,0 18 993,0 781 085,0 -386 784,0

Balance Sheet

Annual, most recent first
Metric FY2022 FY2021 FY2020 FY2019 FY2018
Total Assets 19,76 M 18,30 M 17,42 M 18,38 M 22,17 M
Total Liabilities 20,07 M 21,74 M 19,53 M 19,60 M 20,71 M
Shareholders' Equity -310 854,0 -3,43 M -2,11 M -1,22 M 1,47 M
Total Debt — — — — —
Cash & Equivalents 147 854,0 553 190,0 1,19 M 1,10 M 844 314,0
Current Assets 13,77 M 12,82 M 12,62 M 15,17 M 17,18 M
Current Liabilities 12,39 M 9,94 M 7,25 M 7,96 M 7,12 M